Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sterling Winthrop

Executive Summary

Licenses Feridex liver cancer magnetic resonance imaging agent from Advanced Magnetics. Under the agreement announced Sept. 28, Sterling will make payments of up to $7.75 mil. in exchange for marketing rights in the U.S., Canada, Mexico and Australia. Sterling's Sanofi Winthrop will market product. Advanced Magnetics says it plans to file an NDA for the contrast agent by March 1994. The Cambridge, Mass.-based firm will receive royalties on sales of Feridex and payment for the supply of the product to Sterling.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS023412

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel